Takara Bio Inc. (TYO: 4974)

Takara Bio Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	39,957	35,416	51,847	23,633	25,993	18,266
Short-Term Investments	-	-	-	-	-	2,000
Cash & Short-Term Investments	39,957	35,416	51,847	23,633	25,993	20,266
Cash Growth	4.02%	-31.69%	119.38%	-9.08%	28.26%	6.48%
Receivables	9,149	11,285	12,448	17,804	12,585	9,046
Inventory	12,798	11,850	11,087	24,065	9,183	7,593
Other Current Assets	1,867	4,208	2,187	2,639	1,354	1,482
Total Current Assets	63,771	62,759	77,569	68,141	49,115	38,387
Property, Plant & Equipment	50,630	49,075	40,956	36,395	29,766	24,213
Long-Term Investments	2,318	556	560	476	420	274
Goodwill	7,005	6,488	6,674	6,309	6,149	7,006
Other Intangible Assets	1,554	1,539	2,373	2,850	3,224	4,349
Long-Term Deferred Tax Assets	-	833	1,067	1,539	1,075	779
Other Long-Term Assets	2	2	3	2	1	1
Total Assets	125,280	121,252	129,202	115,712	89,750	75,009
Accounts Payable	850	1,543	2,323	1,959	2,077	1,027
Accrued Expenses	923	962	1,065	923	739	557
Current Portion of Leases	-	180	151	137	138	134
Current Income Taxes Payable	291	2,047	5,077	9,941	6,057	3,007
Other Current Liabilities	4,644	2,436	5,759	4,420	4,180	1,523
Total Current Liabilities	6,708	7,168	14,375	17,380	13,191	6,248
Long-Term Leases	-	788	821	910	1,003	986
Long-Term Deferred Tax Liabilities	-	-	179	198	-	-
Other Long-Term Liabilities	1,305	411	382	373	454	402
Total Liabilities	9,126	9,469	16,749	19,649	15,448	8,419
Common Stock	14,965	14,965	14,965	14,965	14,965	14,965
Additional Paid-In Capital	32,893	32,893	32,893	32,893	32,893	32,893
Retained Earnings	51,937	53,471	57,047	45,009	27,085	18,501
Comprehensive Income & Other	16,024	10,175	7,313	3,005	-761	136
Total Common Equity	115,819	111,504	112,218	95,872	74,182	66,495
Minority Interest	335	279	235	191	120	95
Shareholders' Equity	116,154	111,783	112,453	96,063	74,302	66,590
Total Liabilities & Equity	125,280	121,252	129,202	115,712	89,750	75,009
Total Debt	-	968	972	1,047	1,141	1,120
Net Cash (Debt)	39,957	34,448	50,875	22,586	24,852	19,146
Net Cash Growth	4.02%	-32.29%	125.25%	-9.12%	29.80%	0.59%
Net Cash Per Share	331.83	286.08	422.50	187.57	206.39	159.00
Filing Date Shares Outstanding	120.42	120.42	120.42	120.42	120.42	120.42
Total Common Shares Outstanding	120.42	120.42	120.42	120.42	120.42	120.42
Working Capital	57,063	55,591	63,194	50,761	35,924	32,139
Book Value Per Share	961.83	925.99	931.92	796.18	616.05	552.21
Tangible Book Value	107,260	103,477	103,171	86,713	64,809	55,140
Tangible Book Value Per Share	890.75	859.33	856.79	720.11	538.21	457.91

Source: S&P Capital IQ. Standard template. Financial Sources.